Skip to search formSkip to main contentSkip to account menu

SGB 1534

Known as: SGB-1534 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Quinazolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Strafbarkeit wegen Betrugs bei Abrechnung von unter Verstoß gegen Rahmenverträge oder das Depotverbot aus §128 SGB V erbrachten Hilfsmittelleistungen
Zusammenfassung1. Die unter Verstoß gegen Rahmenverträge oder das Depotverbot aus §128 SGB V erbrachten Leistungen begründen… 
1988
1988
Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin…
Serotonin has an important role in the control of blood pressure, because serotonin2 (5HT2) antagonists ameliorate hypertension… 
1988
1988
Effect of 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monophydrochloride (SGB-1534), an antihypertensive agent, on 3H-prazosin and 3H-p-aminoclonidine binding to alpha…
In order to assess the antihypertensive activities of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2, 4-(1H, 3H… 
1985
1985
Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats.
The antihypertensive activities of SGB-1534, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4 (1H,3H)-quinazolinedione… 
1985
1985
Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
The present in vivo and in vitro experiment was designed to examine the hypotensive mechanisms of 3-[2-[4-(o-methoxyphenyl)-1… 
1985
1985
Cardiovascular effects of a novel antihypertensive agent, SGB-1534, in miniature pigs.
The cardiovascular effects of SGB-1534 (3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]-2,4(1H,3H)-quinazolinedione monohydrochloride…